GO:0008467 [heparan sulfate]-glucosamine 3-sulfotransferase activity

Heparan sulfate (HS) is a linear polysaccharide attached to core proteins, forming heparan sulfate proteoglycans (HSPGs) that modulate numerous biological processes, including cell signaling, development, and inflammation. The functional diversity of HS largely depends on its sulfation pattern, which is generated by a family of sulfotransferases. Among these, the [heparan sulfate]-glucosamine 3-sulfotransferase (3-OST) activity, encoded by GO:0008467, catalyzes the transfer of a sulfate group to the 3-O position of glucosamine residues within HS chains. This modification is relatively rare but critically important for creating specific binding sites for proteins such as antithrombin, fibroblast growth factors, and viral envelope glycoproteins. The 3-O-sulfation reaction is carried out by a family of enzymes known as heparan sulfate 3-O-sulfotransferases (HS3STs), which exhibit distinct but overlapping substrate specificities and tissue distributions. The importance of this activity is underscored by its involvement in various pathological conditions. For instance, epigenetic silencing of the HS3ST2 gene, which encodes a 3-O-sulfotransferase, has been associated with endometrial cancer and hyperplastic endometrial lesions, suggesting a tumor-suppressive role. Understanding the molecular mechanisms and regulation of GO:0008467 is therefore essential for elucidating its contributions to normal physiology and disease. Researchers studying GO:0008467 aim to decipher how 3-O-sulfation patterns are established, how they are altered in disease states, and how they can be targeted therapeutically. This article provides a comprehensive overview of the enzymatic activity, the genes involved, its biological significance, and the experimental approaches, including CRISPR-based models, used to investigate it.

GO:0008467, [heparan sulfate]-glucosamine 3-sulfotransferase activity, is a molecular function defined by the catalysis of the reaction: alpha-D-glucosaminyl-[heparan sulfate](n) + 3'-phosphoadenylyl sulfate = 3-sulfo-alpha-D-glucosaminyl-[heparan sulfate](n) + adenosine 3',5'-bisphosphate + H+. In simpler terms, this activity transfers a sulfate group from the universal sulfate donor PAPS to the 3-O position of a glucosamine unit within a heparan sulfate chain, thereby modifying the sugar's chemical properties. This reaction is a key step in the biosynthesis of heparan sulfate, contributing to the structural heterogeneity that underlies its diverse biological functions.

The 3-O-sulfation of heparan sulfate is a rare but pivotal modification that dictates the interaction of HS with a wide array of proteins, including growth factors, cytokines, and pathogens. This modification is essential for processes such as embryonic development, angiogenesis, and blood coagulation. Dysregulation of 3-O-sulfotransferase activity has been linked to cancer, where altered sulfation patterns can promote tumor growth and metastasis. For example, methylation-induced silencing of HS3ST2 is observed in endometrial cancer and hyperplastic lesions, highlighting its potential as a biomarker and therapeutic target. Thus, understanding GO:0008467 is critical for both basic biology and translational research.

The following genes encode enzymes or related proteins that carry out or regulate [heparan sulfate]-glucosamine 3-sulfotransferase activity.

The activity of [heparan sulfate]-glucosamine 3-sulfotransferases is regulated at multiple levels. Transcriptionally, the expression of HS3ST genes is controlled by tissue-specific transcription factors and can be epigenetically silenced through promoter methylation, as demonstrated for HS3ST2 in endometrial cancer. Post-translational modifications and the availability of the sulfate donor PAPS also influence enzymatic activity. Additionally, the composition of the heparan sulfate substrate, which is determined by other sulfotransferases and modifying enzymes, dictates whether 3-O-sulfation can occur.

Epigenetic silencing of HS3ST2 through promoter methylation has been identified as a frequent event in endometrial cancer and hyperplastic endometrial lesions. This suggests that loss of 3-O-sulfotransferase activity may contribute to tumorigenesis, possibly by altering growth factor signaling. The methylation status of HS3ST2, along with KLF4, has been proposed as a predictive biomarker for endometrial cancer.

Certain viruses, including herpes simplex virus type 1, utilize 3-O-sulfated heparan sulfate as a co-receptor for cellular entry. The presence of specific 3-O-sulfotransferase isoforms can therefore determine host susceptibility to infection, making these enzymes potential targets for antiviral strategies.

The 3-O-sulfation of heparan sulfate is critical for generating the antithrombin-binding pentasaccharide sequence, which is essential for the anticoagulant activity of heparin. Alterations in 3-O-sulfotransferase activity could impact hemostasis and thrombosis risk.

Direct measurement of 3-O-sulfotransferase activity can be performed using radiolabeled PAPS (35S-PAPS) and heparan sulfate acceptors, followed by separation of products by chromatography. These assays are essential for determining kinetic parameters and substrate specificity of HS3ST isoforms.

Liquid chromatography-tandem mass spectrometry (LC-MS/MS) of heparan sulfate disaccharides can quantify the levels of 3-O-sulfated glucosamine residues, providing a comprehensive view of sulfation patterns in cells or tissues. This method is crucial for assessing the impact of genetic manipulations on HS composition.

Methylation-specific PCR and bisulfite sequencing can determine the methylation status of HS3ST2 promoter, as demonstrated in endometrial cancer studies. Quantitative RT-PCR and Western blotting are used to measure mRNA and protein levels of HS3STs.

CRISPR knockout, point mutation, and knock-in models enable precise dissection of HS3ST gene function in relevant cell types. These approaches can be combined with phenotypic assays, such as cell proliferation, migration, and viral infection, to link specific enzymatic activities to biological outcomes.

Researchers studying [heparan sulfate]-glucosamine 3-sulfotransferase activity-related genes often need to determine whether a candidate gene is causally involved in a specific biological process or disease. EDITGENE provides a comprehensive suite of CRISPR-based services to facilitate these investigations, from gene knockout to precise point mutations and overexpression.

GO:0008467, [heparan sulfate]-glucosamine 3-sulfotransferase activity, represents a critical enzymatic function in heparan sulfate biosynthesis, influencing a wide range of biological processes from development to disease. The involvement of HS3ST2 in endometrial cancer highlights the clinical relevance of this activity. Continued research using advanced CRISPR models and glycan analysis will further unravel the complexities of 3-O-sulfation and its potential as a therapeutic target. EDITGENE is committed to supporting this research with state-of-the-art gene editing services, enabling precise manipulation of HS3ST genes and accelerating discoveries in glycobiology and oncology.